- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (384)
- Timeline of Article Publication (1)
- Authors Evaluation (3)
- Article Quality Tracking (0)
- Reader Comments (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4201)
All Articles published online
|
Publishing Process of This Article
|
Apr 7, 2024 (publication date) through Feb 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kojima K, Watanabe K, Kawai M, Yagi S, Kaku K, Ikenouchi M, Sato T, Kamikozuru K, Yokoyama Y, Takagawa T, Shimizu M, Shinzaki S. Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis. World J Gastroenterol 2024; 30(13): 1871-1886 [PMID: 38659488 DOI: 10.3748/wjg.v30.i13.1871] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i13/1871.htm |
| Number | Citing Articles |
| 1 |
Benedetto Neri, Roberto Mancone, Mariasofia Fiorillo, Sara Concetta Schiavone, Stefano Migliozzi, Livia Biancone. Efficacy and Safety of Janus Kinase-Inhibitors in Ulcerative Colitis. Journal of Clinical Medicine 2024; 13(23): 7186 doi: 10.3390/jcm13237186
|
| 2 |
Soichi Yagi, Hirokazu Fukui, Maiko Ikenouchi, Tetsuya Shiraishi, Koji Kaku, Midori Wakita, Yasuhiro Takagi, Toshiyuki Sato, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Tetsuya Takagawa, Toshihiko Tomita, Shinichiro Shinzaki. Continuous Treatment with Tofacitinib but Not Filgotinib Is Effective in Non-Responders with Active Ulcerative Colitis: A Propensity Score-Matching Analysis. Journal of Clinical Medicine 2025; 14(1): 217 doi: 10.3390/jcm14010217
|
| 3 |
Sara R Lopes, Claudio Martins, Madalena Teixeira, David Tomás. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis. World Journal of Gastroenterology 2024; 30(34): 3929-3931 doi: 10.3748/wjg.v30.i34.3929
|
| 4 |
|
| 5 |
Akira Nogami, Kunio Asonuma, Shinji Okabayashi, Maiko Ikenouchi, Takahisa Matsuda, Shinichiro Shinzaki, Masayuki Fukata, Taku Kobayashi. Real‐World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study. United European Gastroenterology Journal 2024; 12(10): 1357 doi: 10.1002/ueg2.12704
|
| 6 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 7 |
Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942
|
| 8 |
D. I. Trukhan. Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects. Meditsinskiy sovet = Medical Council 2024; (15): 200 doi: 10.21518/ms2024-344
|
| 9 |
Zong-Qiang Han, Li-Na Wen. Tofacitinib for ulcerative colitis: A promising treatment option. World Journal of Gastroenterology 2024; 30(40): 4386-4392 doi: 10.3748/wjg.v30.i40.4386
|